The COVID-19 pandemic caused an unprecedented burden on healthcare and significantly disrupted household economies that reshaped households’ expenditure patterns, particularly in health-related expenditure. High out-of-pocket health expenditure (OOPHE) inherently exposed households at risk of incurring catastrophic health expenditure (CHE). This study aimed to investigate the incidence and key determinants of CHE in the post-pandemic period among households in a southern state of Malaysia. A cross-sectional survey was conducted in Negeri Sembilan, a southern state of Malaysia between February and August 2024. A total of 400 head of households participated via proportionate stratified sampling. CHE was defined as the amount of OOPHE exceeding 10% of the monthly household’s expenditure. Descriptive analysis was performed to examine the sociodemographic characteristics of household heads and to determine the median monthly OOPHE (in MYR), while regression analysis was conducted to identify the determinants of CHE. The incidence of CHE was 16.8%. The determinants of CHE included smallest household size (aOR;2.874, 95% CI;1.317,6.271), household in Rembau district (aOR;13.191, 95% CI;3.061,56.843), household with higher education (aOR;2.995, 95% CI:1.599,5.609), and those who are not working (aOR;2.566, 95% CI;1.349,4.880). The post-pandemic incidence of CHE among households in Negeri Sembilan, Malaysia was high. Lower household size, district’s location, higher educational level and lack of occupation were significant determinants of CHE. Findings from this study highlight the urgent need for regular monitoring and targeted financial protection strategies to reduce CHE and promote equitable healthcare access in the post-pandemic period.

The authors have declared no competing interest.

Yes

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Not Applicable

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The ethics approval was obtained from the Human Research and Ethics Committee, Universiti Sains Islam Malaysia. Approval number: USIM/JKEP/2023-278 Informed written consent was obtained from each participant using a physical consent form.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Not Applicable

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Not Applicable

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Not Applicable

Data cannot be shared publicly because it is the property of Universiti Sains Islam Malaysia and the Ministry of Higher Education. Data are available from the USIM Research and Innovation Management Centre (contact via https://pppi.usim.edu.my/) for researchers who meet the criteria for access to confidential data. The data underlying the results presented in the study are available from the USIM Research and Innovation Management Centre.